BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34989251)

  • 1. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, Cancer Antigen 153 and Cancer Antigen 125 in Metastatic Breast Cancer.
    Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
    Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
    Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Propensity Score Matched Study of the Preoperative C-Reactive Protein to Albumin Ratio and Prognosis in Patients with Resectable Non-Metastatic Breast Cancer.
    Zhou L; Ma S; Balde AI; Han S; Cai Z; Li Z
    Med Sci Monit; 2019 Jun; 25():4342-4352. PubMed ID: 31182704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
    Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
    Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
    Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
    Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
    Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
    Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients.
    Sicking I; Edlund K; Wesbuer E; Weyer V; Battista MJ; Lebrecht A; Solbach C; Grinberg M; Lotz J; Hoffmann G; Rahnenführer J; Hengstler JG; Schmidt M
    PLoS One; 2014; 9(10):e111306. PubMed ID: 25340395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data.
    Guo G; Chen X; He W; Wang H; Wang Y; Hu P; Rong Y; Fan L; Xia L
    PLoS One; 2018; 13(12):e0208547. PubMed ID: 30513126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic score for patients with advanced melanoma treated with ipilimumab.
    Diem S; Kasenda B; Martin-Liberal J; Lee A; Chauhan D; Gore M; Larkin J
    Eur J Cancer; 2015 Dec; 51(18):2785-91. PubMed ID: 26597444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer.
    Haas M; Laubender RP; Stieber P; Holdenrieder S; Bruns CJ; Wilkowski R; Mansmann U; Heinemann V; Boeck S
    Tumour Biol; 2010 Aug; 31(4):351-7. PubMed ID: 20480409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer.
    Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
    Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Lactate Dehydrogenase in Patients Undergoing Surgical Resection for Laryngeal Squamous Cell Carcinoma.
    Guo E; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Guo J; Sun J; Meng H; Chang R; Li X; Xiu C; Mao X; Miao S
    Cancer Control; 2020; 27(1):1073274820978795. PubMed ID: 33297727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
    Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
    Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
    Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
    Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
    Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
    Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma.
    Zhang XK; Zhang ZL; Lu X; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Clin Genitourin Cancer; 2016 Aug; 14(4):341-345.e3. PubMed ID: 26868330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.
    Cui Z; Chen Y; Hu M; Lin Y; Zhang S; Kong L; Chen Y
    Clin Chim Acta; 2020 Apr; 503():203-209. PubMed ID: 31794764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
    Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
    Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.